dm+d
40820003
Articles
Specific medicine switches for solid dose and liquid formulations
13 September 2023
Example medicines to prescribe by brand name in primary care
27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.
Carbamazepine monitoring
6 July 2021
How should medicines be dosed in children who are obese?
28 May 2021Review on how to calculate medicine doses in children who are obese which includes a table on commonly prescribed medicines.
The Use of Generic Anti Epileptics Drugs in Patients with Epilepsy
28 September 2020Consensus views of the Pharmaceutical Market Support Group and the UK Clinical Pharmacists Association: Neurosciences Group on the safety and appropriateness of switching between brand…
Medicine Compliance Aid Stability
TegretolNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Tegretol
Tablets 100mg, 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.
8 November 2022
Tegretol prolonged releaseNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
Tegretol prolonged release
Tablets m/r 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
7 November 2022
TegretolEssential Pharma Ltd
Essential Pharma Ltd
Tegretol
Chewtabs 100mg, 200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.
8 November 2022
genericNon-proprietary
Non-proprietary
generic
Tablets 100mg, 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container. Protect from light.
8 November 2022
Carbagen SRGenerics UK Ltd
Generics UK Ltd
Carbagen SR
Tablets f/c m/r 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture and maximum of 8 days in MCA. Store in airtight container.
7 November 2022
Lactation Safety Information
For bipolar disorder
For bipolar disorder
Appropriate second generation antipsychotic
Significant published evidence of use in breastfeeding
Significant amounts in breast milk
Case reports of sedation, poor suckling, withdrawal reactions, and hepatic dysfunction reported in infants exposed to carbamazepine via breast milk
Monitor infant for signs of sedation, poor feeding ad liver dysfunction
3 January 2018
Oral / Rectal For epilepsy
Oral / Rectal
For epilepsy
Suitable alternative antiepileptic
Significant published evidence of use in breastfeeding
Relatively high, but subtherapeutic, amounts in breast milk
Case reports of sedation, poor suckling, regurgitation with vomiting, withdrawal reactions, and hepatic dysfunction in infants exposed to carbamazepine via breast milk
Monitor infant for GI symptoms and signs of liver dysfunction
18 September 2018